Skip to content

Adaptation and Testing of a Novel Text-based Tobacco Cessation and Education Intervention in Kenyan Emergency Department Patients

Adaptation and Testing of a Novel Text-based Tobacco Cessation and Education Intervention in Kenyan Emergency Department Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07734727
Acronym
Text2Quit
Enrollment
285
Registered
2026-07-29
Start date
2026-08-01
Completion date
2028-06-01
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use, Tobacco Use Cessation

Keywords

Kenya, Africa, Noncommunicable disease, global health

Brief summary

In this study, investigators will adapt and implement Text2Quit in a Kenyan ED population will increase knowledge and cessation. Investigators will use a mixed-methods, hybrid implementation-effectiveness approach to assess these outcomes. Results will inform a randomized, controlled trial in a nationally representative sample of EDs in future. This study will be the first to target tobacco use in this population, the first to use mobile cessation, and will contribute to advancing implementation science on tobacco cessation globally. It will also provide a novel approach to implementation for mHealth interventions, with findings that can be generalized to other Non-Communicable Diseases and risk factors, such as alcohol use, hypertension and diabetes.

Detailed description

Aim 1. To assess tobacco use and willingness to engage with mHealth for tobacco cessation targeting Kenyan ED patients. Aim 2. To adapt the Text2Quit mHealth tool for use in the Kenya context using a participatory approach. Aim 3. To pilot test Text2Quit-Kenya and assess its acceptability, feasibility, and efficacy. The focus of this registration is Aim 3.

Interventions

OTHERText2Quit-Kenya

A text message-based mHealth tool addressing tobacco cessation. The program is organized around automated, bidirectional text messages timed for a user's quit date. Messages based on social cognitive theory prompt users to track smoking, report on cravings and on smoking status.

Sponsors

Yale University
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Current tobacco users (self-identified smokers). * Presenting to the Emergency Department (ED) at Kenyatta National Hospital (KNH). * Own a mobile phone capable of receiving text messages. * Willing to quit tobacco use. * Able and willing to provide informed consent.

Exclusion criteria

* Individuals unwilling or unable to provide consent. * Non-tobacco users. * Those without access to a mobile phone. * Patients who are critically ill or otherwise unable to participate (practically excluded at triage).

Design outcomes

Primary

MeasureTime frameDescription
Text2Quit Survey to assess efficacyBaseline and 1 Month post interventionEfficacy will be assessed by self-report binary quantitative outcome of tobacco use in past 7 days
Exhaled Carbon Monoxide testing to assess efficacyBaseline, Month 1 and Month 6Efficacy will be assessed by repeat exhaled Carbon Monoxide testing. Will be assessed using both a binary assessment with a cutoff of 10% and a continuous assessment of percent point prevalence

Secondary

MeasureTime frameDescription
Percent enrollmentBaselinePercent enrollment per arm using Reach RE-AIM Framework
Adoption assessed using Adoption RE-AIM Frameworkup to Month 6This is a qualitative outcome. The measure will be assessed using a semi-structured interview guide informed by the RE-AIM Adoption framework. Interview transcripts will undergo thematic analysis to identify themes related to intervention adoption, future use, and perceived fit within the target community.
Facililtators -Implementationup to Month 6Facililtators assessed using semi-structured qualitative interviews guided by the RE-AIM Implementation framework, with thematic analysis used to identify themes.
Barriers-Implementationup to Month 6Barriers assessed using semi-structured qualitative interviews guided by the RE-AIM Implementation framework, with thematic analysis used to identify themes.
Frequency of message deliveryup to Month 6Frequency of message delivery using Implementation RE-AIM Framework
Frequency of message readBaseline, Month 1 and Month 6Frequency of message read using Implementation RE-AIM Framework
Frequency of responseup to Month 6Absolute and proportion of response to interactive messages using Implementation RE-AIM Framework
Maintenance assessed using RE-AIM FrameworkMonth 6Assesses the long-term sustainability of an intervention by measuring two key levels: individual long-term effects and setting-level institutionalization.
CostMonth 6Number of texts sent x cost per text to obtain individual user cost using Implementation RE-AIM Framework
Tobacco Policies KnowledgeBaseline and Month 1Change in knowledge on tobacco policies using qualitative measure based on Efficacy RE-AIM Framework
Tobacco Harms KnowledgeBaseline and Month 1Change in knowledge on tobacco harms of use using qualitative measure based on Efficacy RE-AIM Framework. Mean count of correct responses to the tobacco harms knowledge items, with scores ranging from 0 to 5 (higher scores indicate greater knowledge).
Tobacco Use FrequencyBaseline and Month 1Frequency of tobacco use using Efficacy RE-AIM Framework
Mean Tobacco Cessation AttemptsBaseline and Month 1Mean number of tobacco cessation attempts using Efficacy RE-AIM Framework
Absolute Number Tobacco Cessation AttemptsBaseline and Month 1Absolute number of tobacco cessation attempts using Efficacy RE-AIM Framework

Countries

Kenya

Contacts

CONTACTChristine Ngaruiya, MD MSC DTMH
cngaruiya@stanford.edu650-723-6576
CONTACTJessica Rayo, MS
jrayo@stanford.edu559-759-4266
PRINCIPAL_INVESTIGATORChristine Ngaruiya, MD MSC DTMH

Stanford School of Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026